 Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel, March 24, 2022 PRNewswire -- Protalix BioTherapeutics, Inc. NYSE American: PLX TASE: PLX, a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, today announced that it will release its financial results for fiscal year 2021 and provide a business update on Thursday, March 31, 2022. 